I help turn strong science into successful products — by aligning innovation and commercial strategy from the very beginning

Technical Expertise, Anchored in Commercial Reality

I support companies across:

• Therapeutics (rare disease, oncology, immunology, neuroscience)

• Diagnostics & precision medicine

• Digital health and ML-enabled platforms

I work with teams to:

• Translate complex science into clear value propositions

• Align clinical strategy with future market access

• Stress-test assumptions early (population, endpoints, comparators)

• Ensure development plans support future reimbursement and adoption

This ensures innovation is not only scientifically sound — but commercially viable.

🔹 Market Positioning & Competitive Differentiation

A strong technology alone is not enough.

I help companies:

• Define true differentiation vs. standard of care

• Position assets clearly against competitors and pipelines

• Identify white space in crowded markets

• Build narratives that resonate with:

  • Investors

  • Partners

  • Payers

  • Regulators

This includes:

• Competitive landscape mapping

• Target Product Profiles (TPPs)

• Value messaging by stakeholder

• Early brand & indication strategy

🔹 Market Sizing, Forecasting & Investment Readiness

I bring strong expertise in:

• Epidemiology-based market sizing

• Segmentation by line of therapy, biomarker, geography

• Revenue modelling (7–10 year forecasts)

• Scenario modelling (best / base / downside)

• Peak sales logic aligned to access realities

Importantly, I align forecasts with:

• Regulatory pathways

• Pricing and reimbursement constraints

• Regional market differences (US, EU, RoW)

This ensures projections are credible, defensible, and investor-ready.

🔹 Global Market Access Awareness — A Key Differentiator

A core strength I bring is early access thinking.

I help teams understand:

• How HTA bodies evaluate value

• What drives reimbursement in EU vs US

• The impact of evidence, endpoints, and comparators

• How access strategy should shape development decisions

This avoids late-stage surprises and ensures:
✔ Faster uptake
✔ Stronger pricing potential
✔ Better partner interest

🔹 Why Meet Me at This Event?

If you are:

• A startup building a platform or asset

• A founder preparing for funding or partnering

• A scientist looking to translate innovation to impact

• An investor assessing commercial readiness

I can help you:

• Pressure-test your strategy

• Sharpen your value proposition

• Strengthen your pitch

• Align science with market reality

“I help turn strong science into successful products — by aligning innovation, market access, and global commercial strategy from the very beginning.”